XULTOPHY 100/3.6

insulin degludec and liraglutide · Novo Nordisk

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for XULTOPHY 100/3.6, covering 2016-11-21 to 2025-10-14. Get the full timeline:

Most recent: FDA Approved: XULTOPHY 100/3.6 — Supplemental Application (Novo Nordisk)